Patent holdings for IPC class A61K 31/122

Total number of patents in this class: 2789

10-year publication summary

240
230
264
273
267
273
306
282
237
61
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Kaneka Corporation
4445
52
BPGbio Inc.
82
26
PTC Therapeutics, Inc.
492
25
Golden Biotechnology Corporation
32
22
DSM IP Assets B.V.
5856
21
Epizon Pharma, Inc.
30
18
U.S. Nutraceuticals, L.L.C., DBA Valensa International
30
18
Société des Produits Nestlé S.A.
9672
15
Lantern Pharma Inc.
62
15
The Regents of the University of California
18943
14
Berg LLC
70
14
Indiana University Research and Technology Corporation
808
13
Nattopharma AS
15
13
Ic-medtech Corporation
16
12
LTS Lohmann Therapie-Systeme AG
691
12
University of South Florida
1817
11
Pellficure Pharmaceuticals, Inc.
14
11
The United States of America, as represented by the Secretary, Department of Health and Human Services
2737
11
U.S. NUTRACEUTICALS, LLC d/b/a Valensa International
24
11
President and Fellows of Harvard College
5792
10
Other owners 2445